RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación
Artículo científico (JournalArticle)
Transient glyco-engineering to produce recombinant IgA1 with defined N-and O-glycans in plants
[EN] The production of therapeutic antibodies to combat pathogens and treat diseases, such
as cancer is of great interest for the biotechnology industry. The recent development of
plant-based expression systems has demonstrated that plants are well-suited for the
production of recombinant monoclonal antibodies with defined glycosylation. Compared
to immunoglobulin G (IgG), less effort has been undertaken to express immunoglobulin
A (IgA), which is the most prevalent antibody class at mucosal sites and a promising
candidate for novel recombinant biopharmaceuticals with enhanced anti-tumor activity.
Here, we transiently expressed recombinant human IgA1 against the VP8* rotavirus
antigen in glyco-engineered XT/FT Nicotiana benthamiana plants. Mass spectrometric
analysis of IgA1 glycopeptides revealed the presence of complex biantennary N-glycans
with terminal N-acetylglucosamine present on the N-glycosylation site of the CH2
domain in the IgA1 alpha chain. Analysis of the peptide carrying nine potential
O-glycosylation sites in the IgA1 alpha chain hinge region showed the presence of
plant-specific modifications including hydroxyproline formation and the attachment of
pentoses. By co-expression of enzymes required for initiation and elongation of human
O-glycosylation it was possible to generate disialylated mucin-type core 1 O-glycans on
plant-produced IgA1. Our data demonstrate that XT/FT N. benthamiana plants can
be engineered toward the production of recombinant IgA1 with defined human-type Nand
O-linked glycans., This work was supported by a grant from the Austrian Federal Ministry of Transport, Innovation and Technology (bmvit) and Austrian Science Fund (FWF): TRP 242-B20 and by the Austrian Research Promotion Agency (Laura Bassi Center of Expertise "Plant produced Bio-Pharmaceuticals" Grant Nr. 822757).